Yamauchi Y, Nagasawa K, Tada Y, Tsukamoto H, Yoshizawa S, Mayumi T, Niho Y, Kusaba T
First Department of Internal Medicine, Faculty of Medicine, Kyushu University.
Kansenshogaku Zasshi. 1991 Jul;65(7):851-6. doi: 10.11150/kansenshogakuzasshi1970.65.851.
We determined the incidence of herpes zoster (HZ) in 119 patients with systemic lupus erythematosus (SLE). HZ occurred in 56 patients (47%), and 9 patients had had HZ even before SLE developed. After diagnosis of SLE, an incidence of zoster was high, 5.45 cases per 100 person-years. It was found that the susceptibility to HZ was not related to the presence of renal disorder or maximum dose of corticosteroids. The patients with SLE who had had HZ showed significantly higher antibody titers than those without a history of HZ and normal subjects as assayed by both complement fixation technique and neutralization test. On the other had, only 17 of 55 patients (31%) with SLE showed positive skin reactions to varicella zoster virus (VZV) antigen, whereas all 15 normal subjects had positive reactions. In the patients who were receiving less than 10 mg/day of prednisolone, 11 of 17 (65%) had positive skin reactions to VZV antigen, whereas only 4 of 31 (13%) patients who were receiving 10 mg/day or more prednisolone showed positive reactions. It was of interest that in 7 patients with SLE who had not received corticosteroids, only 2 (29%) patients showed positive skin reactions to VZV antigen. These results suggest that high incidence of HZ in patients with SLE is probably due to an impaired cellular immunity because of both underlying disease and corticosteroid treatment.
我们确定了119例系统性红斑狼疮(SLE)患者中带状疱疹(HZ)的发病率。HZ发生在56例患者中(47%),甚至有9例患者在SLE发病前就已患过HZ。SLE确诊后,带状疱疹的发病率很高,为每100人年5.45例。研究发现,对HZ的易感性与肾脏疾病的存在或皮质类固醇的最大剂量无关。通过补体结合技术和中和试验检测,患过HZ的SLE患者的抗体滴度显著高于无HZ病史的患者和正常受试者。另一方面,55例SLE患者中只有17例(31%)对水痘带状疱疹病毒(VZV)抗原的皮肤反应呈阳性,而所有15名正常受试者均呈阳性反应。在接受泼尼松龙每日剂量低于10 mg的患者中,17例中有11例(65%)对VZV抗原的皮肤反应呈阳性,而在接受泼尼松龙每日剂量10 mg或更高的31例患者中,只有4例(13%)呈阳性反应。有趣的是,在7例未接受皮质类固醇治疗的SLE患者中,只有2例(29%)对VZV抗原的皮肤反应呈阳性。这些结果表明,SLE患者中HZ的高发病率可能是由于基础疾病和皮质类固醇治疗导致细胞免疫受损。